Objective: To estimate the effect of locally tailored clinical guidelines on intrapartum care and perinatal outcomes among women with severe hypertensive disorders in pregnancy (sHDP).
| INTRODUCTION
Hypertensive disorders in pregnancy (HDP) cause one-tenth of maternal deaths in Africa.
1,2 A previous facility-based survey in low-and middle-income countries found that the likelihood of maternal nearmiss was eightfold and perinatal death threefold higher in a group of women with pre-eclampsia than in a reference group without HDP.
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Although most cases are preventable, undiagnosed or suboptimally treated HDP is repeatedly reported in sub-Saharan Africa. [3] [4] [5] [6] [7] [8] [9] [10] This violates human rights and is a key priority for safe motherhood. 11, 12 Hypertensive disorders in pregnancy can rapidly progress in severity, with increased risk of organ failure such as cerebral hemorrhage, coagulopathy, eclampsia, and pulmonary edema. Lifesaving treatment includes induction and/or oxytocin augmentation of labor while stabilizing blood pressure (BP) and supporting vital organ functions. 13, 14 In high-volume low-resource hospitals, urgent intrapartum diagnosis, surveillance, and management of such complex diseases are challenging and need realistic practical guidance. 3, [5] [6] [7] [8] [9] 15, 16 In Tanzania, however, only one-third of maternity units have emergency obstetric care guidelines available, and only one-quarter have at least one birth attendant with adequate training in applying these. 17 Even if available, guidelines are often not tailored to lowresource settings. 9, 15, 16, 18 Unachievable international guidelines limit implementation and may demoralize staff. Clinical guidelines tailored and disseminated to facilitate effective application in low-resource settings are required. 15, 17, 18 Zanzibar is a low-income, semiautonomous archipelago of the United Republic of Tanzania, with a facility delivery rate of 55%. In its tertiary Mnazi Mmoja Hospital, approximately 12 000 births are attended to annually. There were 59 stillbirths per 1000 births in 2014-2015, and 52 neonates per 1000 live births had an Apgar score of [1] [2] [3] [4] [5] . Approximately half of the stillborn fetuses were alive on admission, and the quality of intrapartum care was widely unacceptable.
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This prompted, in collaboration with doctors and nurse-midwives, the development of locally achievable clinical guidelines for common intrapartum care. The resulting eight-page PartoMa pocket booklet has subsequently been implemented among doctors and nursemidwives by quarterly seminars. 18 In particular, doctors have reported finding the booklet's page on essential intrapartum management of HDP useful. 18 The aim of the present study was therefore to estimate the effects of the PartoMa intervention of pocket guides and quarterly low-dose training on care and delivery outcomes among women with severe HDP (sHDP).
| MATERIALS AND METHODS
In a retrospective pre-post study, case files were reviewed for all The "PartoMa Pocket Guide" (File S1) was launched on January 27-28, 2015, at the first "PartoMa seminars". These 3-hour seminars were conducted quarterly in order to establish use of the guidelines via case-based discussions. They were conducted outside working hours and without 'per diems' or other allowances. An average of 74% of doctors and 62% of nurse-midwives from the obstetric division attended each of five seminar rounds during the first intervention year. One page of the pocket guide ( Fig. 1 ) and one of five seminar cases concerned intrapartum care for women with sHDP. Detailed descriptions of guidelines development and the seminars are presented elsewhere. 18, 19, 21 Quality of intrapartum care for women with sHDP was delineated to diagnosis, surveillance, and treatment, and based on pre-selected indicators (Fig. S1 ). In addition, maternal background characteristics, maternal mortality, neonatal Apgar score, and stillbirth were recorded, including the proportion of stillbirths with fetal heart rate (FHR) present on admission. The indicators were chosen to represent unambiguous audit criteria for low-resource settings that were sensitive in monitoring progress in care and could be retrieved from case files.
Structural changes at the study site that might potentially explain outcome changes (or lack of changes) after implementation of the PartoMa intervention were assessed quarterly and have been previously described. 19 In brief, staff numbers, supply shortages, and were first presented for staff after the 12th intervention month.
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For the present study, the baseline period was limited to October 1, 2014, to January 31, 2015, because the hospital's case file storage system did not work properly before this period. 19 The intervention period studied, October 1, 2015, to January 31, 2016 (the ninth to 12th intervention months), was previously used in the overall evaluation of PartoMa. 19 For the assessment of sHDP, the calculated sample size for the intervention months was based on a two-sided comparison 
| RESULTS
According to the hospital registers, 3599 women gave birth at baseline and 3002 did so during the four intervention months studied, but case files of 3609 and 3067 women were retrieved from the respective study periods. Of these, 2761 (76.5%) and 2398 (78.2%) women, respectively, had at least one BP measurement, or had eclampsia documented without a BP recording, of whom 188 (6.8%) and 196 (8.2%) fulfilled the criteria for sHDP and were included in the baseline and intervention groups. An additional 848 (23.5%) and 669 (21.8%) of the women retrieved from the study periods had no BP recorded during the whole admission period (RR 0.93, 95% CI 0.85-1.01), respectively, which could lead to an underestimation of sHDP (Fig. 2 ).
The background characteristics of women with sHDP were comparable between the baseline and intervention groups: approximately 40% were nulliparous; 75% had completed 34 weeks (birthweight ≥2000 g) of pregnancy; more than 80% had attended prenatal care at least once and 40% had at least four prenatal visits. Among the multiparous women, 30% had previously lost one or more children (documentation was inadequate to distinguish perinatal deaths from deaths later in life). Labor progress on admission was similarly comparable between the two groups: 50% were admitted before active labor and 2% in the second stage. Fifteen percent were referred from lower level facilities. On admission, 9% were diagnosed with intrauterine fetal death (Table S1 ). Among the 188 women at baseline, 184 (97.9%) had severe hypertension (systolic BP ≥160 mm Hg and/or diastolic BP ≥110 mm Hg) and 70 (37.2%)
had a systolic BP of 180 mm Hg or higher. These proportions were comparable with the intervention group: 193 (98.5%) and 85
(43.4%). The incidence of proteinuria (dipstick measurement ≥2+)
was slightly higher during the intervention months, which might be due to fewer women in this group lacking a urine test (Table S1 ).
The routine BP assessments of all laboring women did not improve between the two periods (RR 0.93, 95% CI 0.85-1.01) ( No BP recording during admission and eclampsia not described
At least one BP recording during admission or eclampsia described:
Severe hypertensive disorders pre-delivery
Severe pre-eclampsia/eclampsia No BP recordings during admission and eclampsia not described:
Severe pre-eclampsia/eclampsia (n = 144) (73%)
Eclampsia
(n = 31) (22%) (Table S1) to 148 (75.5%), respectively (RR 1.17, 95% CI 1.03-1.33) ( Table 3) .
One woman at baseline and five during the intervention months died (RR 4.80, 95% CI 0.57-40.67). The woman at baseline died from obstetric hemorrhage. In the intervention group, one woman died from obstetric hemorrhage, and one had been referred from elsewhere and died on admission. The other three women experienced severe organ dysfunction postpartum in the study hospital; one patient had pulmonary edema and hypoxia, one had eclampsia and cerebral edema, and one had eclampsia and renal failure.
| DISCUSSION
The present findings show that, although care remained substandard, several improvements had occurred during the ninth to 12th invention months, such as progress in surveillance, a 37% increase in antihypertensive treatment, and a 44% reduction in risk of stillbirth.
Taken together with previous studies, 3, 18, 19 the findings suggest that the PartoMa intervention was an important determinant of improvements. This indicates how effective locally tailored clinical guidelines and associated quarterly, low-dose training can be in a weak healthcare system with critical shortages in human resources.
The study has both strengths and limitations. The low-cost, pre-post approach had applicable process and outcome indicators.
The comparable background characteristics of women between baseline and the intervention months strengthened its internal validity. Two baseline periods would have enabled potential timerelated changes to be examined, but the hospital's poor case file storage prevented this approach. There were few contextual confounders identified, but the 16% fewer deliveries in the intervention months might have allowed better care. 19 Birth attendants
were not paid to attend the seminars. Therefore, the high attendance after working hours appeared to indicate staff motivation to improve care, which was a mediator of improvements. 19 Through retrieving all available case files from the months studied and reviewing them manually, the number of women in labor identified was 2% higher than if hospital registers alone had been used.
This close approximation in a low-resource hospital was a strength.
The present findings are further strengthened by triangulation with similar results of the other PartoMa studies, emphasizing low inter-observer bias and unambiguity of indicators. 3, 18, 19 Although the effect of the PartoMa intervention was explored in terms of care and birth outcomes, the available case file data did not enable analyzing the frequency of organ failure and neonatal mortality, the in-depth quality of monitoring and treatment, and whether the birth attendants' interactions with the women were respectful.
Furthermore, data from case file reviews might be biased owing to under-or over-recording.
3
The current study shows that the previously reported overall reduction in stillbirths from 59 to 39 per 1000 total births between baseline and the ninth to 12th intervention months 19 was also true within the sHDP subgroup; stillbirths reduced from 20.9% to 11.7%.
Although not reaching statistical significance, the results suggest that the reduction predominantly occurred among intra-hospital stillbirths. Whereas a decrease in over-use of oxytocin augmentation seemed to be a major contributor among non-sHDP women, PartoMa pocket guide that were highest rated among birth attendants (FHR, labor progress, and intrapartum HDP). 18 Furthermore, this is consistent with challenges identified in the baseline casecontrol study of stillbirth. 3 It seems that the PartoMa intervention's integrated recommendations and training in routine and emergency intrapartum care have helped to trigger quality improvements.
Qualitative implementation research is warranted to further identify organizational and individual aspects associated with the changes, and with lack of changes.
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Two other criterion-based audits from East African referral hospitals also included locally tailored guidelines and similarly proved effective in strengthening care for women with HDP. However, their interventions were narrowly targeted at pre-eclampsia/eclampsia and included additional structural changes. 6, 8 To our knowledge, no other studies of broader guidelines have been shown to be effective in strengthening care and perinatal survival for women with HDP in low-income countries.
Nevertheless, the five maternal deaths in the ninth to 12th intervention months reflect the unacceptable quality of care throughout the study. Moreover, the 7%-8% prevalence of severe hypertensive disorders, with 85% of affected women admitted directly from home and only one diagnosed with mild-moderate disease prior to this, might in itself indicate missed opportunities for early detection and treatment, both prenatally and intrapartum. Data from another Tanzanian tertiary hospital reported an incidence of eclampsia of 6%, 6 whereas a facility-based survey of mild-severe HDP in multiple low-and middle-income countries found an overall prevalence of only 2.7%. 2 The high prevalence of sHDP in the present study may also be associated with a high predisposition in the target population, which further emphasizes the need to strengthen early detection and management: 19% of Zanzibari women aged 25-44 years are affected by hypertension, 23 with the risk of gestational aggravation and superimposed pre-eclampsia.
2,24
In quality improvement processes, the potential effects, and adverse effects, of more or less broad focal points must be carefully considered. As part of the internationally formulated obstetric care signal functions, maximizing magnesium sulfate coverage has been repeatedly emphasized. 25 At the study hospital, it was administered to 90% of women with severe pre-eclampsia/eclampsia during both baseline and intervention months. Although evidence suggests that severe hypertension is a similarly important contributor to maternal mortality in sHDP, 14 antihypertensives are not included in the signal functions, and this omission might have contributed to more than half of the women with sHDP at baseline not receiving antihypertensive treatment. A similar mismatch in pre-eclampsia/eclampsia treatment was reported in Ghana, where health providers described how clinical guidelines were adhered to more closely if they were given more attention and if local adjustments were made. training, which takes account of the current resource constraints, are warranted in assisting work-overloaded birth attendants in improving care. Achievable guidance is a basic right for birth attendants holding the lives of others in their hands.
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T A B L E 3 Birth outcomes among women with severe hypertensive disorders, comparison of relative risk of outcomes during the ninth to 12th months of the intervention (October 1, 2015, to January 31, 2016) compared with during the baseline period (October 1, 2014, to January 31, 2015). Values are given as absolute number or number (percentage), unless indicated otherwise. b The last recording in the file was treated as the last day of stay. c Of all neonates, 2/203 (1%) at baseline and 10/206 (4.9%) during the intervention had birthweight <1000 g approximate pregnancy duration <28 wk). At the study hospital, stillbirths at <28 weeks are classified as late spontaneous abortions. Although there might be a risk of mis-categorizing stillbirths affected by severe intrauterine growth restriction, those stillbirths were excluded from the perinatal outcome data.
SUPPORTING INFORMATION
Additional supporting information may be found online in the Supporting Information section at the end of the article. Severe pre-eclampsia (triple asterisk) was defined as severe hypertension on at least one reading and proteinuria of at least 2+, or recorded eclampsia/convulsions before or during admission. Abbreviations:
FHR, fetal heart rate; IUFD, intrauterine fetal death. Table S1 . Background characteristics of women included at baseline and at 9-12 mo of the PartoMa intervention.
